Literature DB >> 2096740

Antinociceptive action of tricyclic antidepressant drugs in the rat.

E V Hersh1, P Kaplan.   

Abstract

The antinociceptive effects of controlled release amitriptyline, desipramine, and placebo pellets were studied over 3 weeks using the hot plate method in 45 rats. Animals treated with desipramine at total doses of 50 mg (8 mg/kg/day) and 100 mg (16 mg/kg/day) displayed analgesia for up to 48 hours compared with the matching placebo groups. Amitriptyline did not produce significant analgesia at the same doses. By 72 hours until the final evaluation period at 21 days, the antinociceptive action of desipramine was no longer evident. These results suggest that relatively small continuously released doses of desipramine produce analgesia within 24 hours in this animal model, but an apparent analgesic tolerance develops within 3 days.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2096740      PMCID: PMC2148668     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  24 in total

1.  Post-traumatic trigeminal neuralgia: response to physiologic, surgical and pharmacologic therapies.

Authors:  J M Gregg
Journal:  Int Dent J       Date:  1978-03       Impact factor: 2.512

2.  Dental sealants in the prevention of tooth decay. NIH Consensus Development Conference summary.

Authors: 
Journal:  Br Dent J       Date:  1984-04-21       Impact factor: 1.626

3.  Antinociceptive activity of opiates in the presence of the antidepressant agent nomifensine.

Authors:  J P Gonzalez; R D Sewell; P S Spencer
Journal:  Neuropharmacology       Date:  1980-07       Impact factor: 5.250

4.  Clomipramine and amitriptyline in the treatment of severe pain.

Authors:  R L Carasso; S Yehuda; M Streifler
Journal:  Int J Neurosci       Date:  1979       Impact factor: 2.292

5.  Amitriptyline versus placebo in postherpetic neuralgia.

Authors:  C P Watson; R J Evans; K Reed; H Merskey; L Goldsmith; J Warsh
Journal:  Neurology       Date:  1982-06       Impact factor: 9.910

6.  Doxepin effects on chronic pain, depression and plasma opioids.

Authors:  S R Hameroff; R C Cork; K Scherer; B R Crago; C Neuman; J R Womble; T P Davis
Journal:  J Clin Psychiatry       Date:  1982-08       Impact factor: 4.384

7.  Diagnosis of temporomandibular joint pain in patients seen at a pain clinic.

Authors:  A N Goss; B Speculand; E Hallet
Journal:  J Oral Maxillofac Surg       Date:  1985-02       Impact factor: 1.895

8.  Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system.

Authors:  M Botney; H L Fields
Journal:  Ann Neurol       Date:  1983-02       Impact factor: 10.422

9.  Controlled trial of imipramine for chronic low back pain.

Authors:  J Alcoff; E Jones; P Rust; R Newman
Journal:  J Fam Pract       Date:  1982-05       Impact factor: 0.493

10.  Augmentation of central and peripheral morphine analgesia by desipramine.

Authors:  M H Ossipov; R T Malseed; F J Goldstein
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-10
View more
  1 in total

1.  A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

Authors:  F S Hall; J M Schwarzbaum; M T G Perona; J S Templin; M G Caron; K-P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2010-12-01       Impact factor: 3.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.